Back to top
more

Brainsway (BWAY)

(Delayed Data from NSDQ)

$11.83 USD

11.83
59,081

-0.01 (-0.08%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $11.79 -0.04 (-0.34%) 5:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Earnings Estimates Rising for Brainsway (BWAY): Will It Gain?

by Zacks Equity Research

Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Wall Street Analysts Think Brainsway (BWAY) Could Surge 38.83%: Read This Before Placing a Bet

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 38.8% in Brainsway (BWAY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

New Strong Buy Stocks for January 14th

by Zacks Equity Research

BWAY, EE, MATW, BRBR and FMAO have been added to the Zacks Rank #1 (Strong Buy) List on January 14, 2025.

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

Zacks Equity Research

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

Solventum Q3 Earnings Likely to Reflect Declining Volume Trend

by Zacks Equity Research

SOLV's Q3 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset sales decline.

Zacks Equity Research

Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings

by Zacks Equity Research

BAX's third-quarter results are likely to benefit from a positive pricing impact and new product launches. However, supply-chain issues are likely to have raised expenses in the quarter.

Zacks Equity Research

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

Zacks Equity Research

Strong Segmental Performance to Drive Stryker's Q3 Earnings

by Zacks Equity Research

SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.

Zacks Equity Research

Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade

by Zacks Equity Research

The consensus price target hints at a 32% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Here's Why Momentum in Brainsway (BWAY) Should Keep going

by Zacks Equity Research

Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

Zacks Equity Research

Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 34.4% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Brainsway (BWAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Zacks.com featured highlights include Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay

by Zacks Equity Research

Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay have been highlighted in this Screen of The Week article.

Zacks Equity Research

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

by Zacks Equity Research

Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Nalak Das headshot

5 Stocks With Recent Price Strength to Enhance Your Portfolio

by Nalak Das

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BYRN, IDR, LMB, SEZL, BWAY.

Anirudha Bhagat headshot

4 Stocks Worth Adding to Your Portfolio on Solid Net Profit Margin

by Anirudha Bhagat

Let's take a look at four top-ranked stocks - BWAY, QFIN, GLDD and GRC - with impressive net profit margins for a robust portfolio.

Zacks Equity Research

Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Butterfly Network, Inc. (BFLY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Zacks Equity Research

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does Brainsway Ltd. Sponsored ADR (BWAY) have what it takes to be a top stock pick for momentum investors? Let's find out.